• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌中Her2阳性与微卫星不稳定性状态——临床病理意义

Her2-Positive and Microsatellite Instability Status in Gastric Cancer-Clinicopathological Implications.

作者信息

Bermúdez Ana, Arranz-Salas Isabel, Mercado Silvia, López-Villodres Juan A, González Virginia, Ríus Francisca, Ortega María V, Alba Carmen, Hierro Isabel, Bermúdez Diego

机构信息

Department of Anesthesiology, Nuestra Señora de Valme University Hospital, 41014 Seville, Spain.

Department of Human Physiology, Human Histology, Anatomical Pathology and Physical Education, University of Malaga, 29010 Malaga, Spain.

出版信息

Diagnostics (Basel). 2021 May 25;11(6):944. doi: 10.3390/diagnostics11060944.

DOI:10.3390/diagnostics11060944
PMID:34070574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8228707/
Abstract

Gastric cancer (GC) is one of the leading causes of cancer-related death. The combination of new molecular classifications with clinicopathological data could contribute to the individualization of patients and to the development of new therapeutic strategies. We examined the various associations in two molecular types of GC: HER2-positive (human epidermal growth factor receptor 2) and microsatellite instability (MSI), assessing their influence on treatment and prognosis. A retrospective study of 142 GC patients was performed with molecular characterization through HER2 overexpression and DNA repair protein expression for MSI. The percentage of HER2-positive tumors was 13.4%, predominantly in men. Correlations were found with intestinal type, metastases, advanced stages and chemotherapy. Almost 75% of HER2-positive patients died. MSI occurred in 16.2%, associated with advanced age, female sex, distal location and intestinal type. These patients had few metastases and low stages. The percentage of deaths was higher among MSI patients who received perioperative chemotherapy. The determination of HER2 and MSI status in GC is important for their association with specific clinicopathological features and for their prognostic and predictive value.

摘要

胃癌(GC)是癌症相关死亡的主要原因之一。新的分子分类与临床病理数据相结合有助于患者的个体化治疗以及新治疗策略的开发。我们研究了两种分子类型的胃癌中的各种关联:HER2阳性(人表皮生长因子受体2)和微卫星不稳定性(MSI),评估它们对治疗和预后的影响。对142例胃癌患者进行了回顾性研究,通过HER2过表达和DNA修复蛋白表达对MSI进行分子特征分析。HER2阳性肿瘤的比例为13.4%,主要见于男性。发现其与肠型、转移、晚期和化疗相关。几乎75%的HER2阳性患者死亡。MSI发生率为16.2%,与高龄、女性、远端部位和肠型相关。这些患者转移较少且分期较低。接受围手术期化疗的MSI患者死亡率较高。确定胃癌中的HER2和MSI状态对于它们与特定临床病理特征的关联以及它们的预后和预测价值很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db17/8228707/e8939b74e96a/diagnostics-11-00944-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db17/8228707/7096f9c0db91/diagnostics-11-00944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db17/8228707/4dcaee5912f9/diagnostics-11-00944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db17/8228707/e8939b74e96a/diagnostics-11-00944-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db17/8228707/7096f9c0db91/diagnostics-11-00944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db17/8228707/4dcaee5912f9/diagnostics-11-00944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db17/8228707/e8939b74e96a/diagnostics-11-00944-g003.jpg

相似文献

1
Her2-Positive and Microsatellite Instability Status in Gastric Cancer-Clinicopathological Implications.胃癌中Her2阳性与微卫星不稳定性状态——临床病理意义
Diagnostics (Basel). 2021 May 25;11(6):944. doi: 10.3390/diagnostics11060944.
2
Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.胃癌患者靶向治疗标志物的表达谱:HER-2、微卫星不稳定性和 PD-L1。
Mol Diagn Ther. 2019 Dec;23(6):761-771. doi: 10.1007/s40291-019-00424-y.
3
Amplification of the human epidermal growth factor receptor 2 () gene is associated with a microsatellite stable status in Chinese gastric cancer patients.人表皮生长因子受体2()基因的扩增与中国胃癌患者的微卫星稳定状态相关。
J Gastrointest Oncol. 2021 Apr;12(2):377-387. doi: 10.21037/jgo-21-47.
4
Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.人表皮生长因子受体 2 表达与胃癌临床病理特征及预后的相关性。
World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.
5
Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.胃癌中人类表皮生长因子受体 2-磷酸肌醇 3-激酶-v-Akt 通路的改变。
World J Gastroenterol. 2012 Dec 7;18(45):6577-86. doi: 10.3748/wjg.v18.i45.6577.
6
Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.从劳伦组织学分型中减去 Epstein-Barr 病毒和微卫星不稳定性基因型:在 1248 例队列中验证的联合分子和组织学亚型与临床病理和预后意义。
Int J Cancer. 2019 Dec 15;145(12):3218-3230. doi: 10.1002/ijc.32215. Epub 2019 Mar 1.
7
[Expression level and prognostic value of PD-L1 in microsatellite instability-high gastric cancer].[程序性死亡受体配体1(PD-L1)在微卫星高度不稳定型胃癌中的表达水平及预后价值]
Zhonghua Bing Li Xue Za Zhi. 2020 Nov 8;49(11):1114-1119. doi: 10.3760/cma.j.cn112151-20200323-00245.
8
Microsatellite Instability Analysis in Gastric Carcinomas of Moroccan Patients.对摩洛哥患者胃癌中微卫星不稳定性的分析。
Genet Test Mol Biomarkers. 2021 Feb;25(2):116-123. doi: 10.1089/gtmb.2020.0146.
9
Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.开发和验证一种易于实施的、实用的胃癌分子亚型识别算法:预后和治疗意义。
Oncologist. 2019 Dec;24(12):e1321-e1330. doi: 10.1634/theoncologist.2019-0058. Epub 2019 Aug 1.
10
Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report.人表皮生长因子受体2阳性及微卫星高度不稳定的晚期胃癌的治疗:一例病例报告
Int Cancer Conf J. 2024 Aug 2;13(4):342-347. doi: 10.1007/s13691-024-00707-0. eCollection 2024 Oct.

引用本文的文献

1
The influence of infection in HER2-positive gastric cancer cell lines: insights from Wnt/β-catenin pathway.感染对HER2阳性胃癌细胞系的影响:来自Wnt/β-连环蛋白信号通路的见解
Front Immunol. 2025 Jun 26;16:1550651. doi: 10.3389/fimmu.2025.1550651. eCollection 2025.
2
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS.微卫星高度不稳定的转移性或复发性胃癌及食管胃交界癌的患病率和临床病理特征:WJOG13320GPS研究
Gastric Cancer. 2025 Mar;28(2):301-308. doi: 10.1007/s10120-024-01579-2. Epub 2024 Dec 31.
3

本文引用的文献

1
From biology to surgery: One step beyond histology for tailored surgical treatments of gastric cancer.从生物学迈向外科手术:超越组织学,实现胃癌的精准手术治疗。
Surg Oncol. 2020 Sep;34:86-95. doi: 10.1016/j.suronc.2020.04.004. Epub 2020 Apr 5.
2
Gastric cancer.胃癌。
Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5.
3
The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer.微卫星高度不稳定(MSI)亚型在胃癌中更好的生存与氧化应激相关通路有关。
Advanced Deep Learning Fusion Model for Early Multi-Classification of Lung and Colon Cancer Using Histopathological Images.
基于组织病理学图像的肺癌和结肠癌早期多分类高级深度学习融合模型
Diagnostics (Basel). 2024 Oct 12;14(20):2274. doi: 10.3390/diagnostics14202274.
4
The potential of retinoic acid receptors as prognostic biomarkers and therapeutic targets in gastric cancer.视黄酸受体作为胃癌预后生物标志物和治疗靶点的潜力。
Front Oncol. 2024 Sep 11;14:1453934. doi: 10.3389/fonc.2024.1453934. eCollection 2024.
5
Transfer learning based approach for lung and colon cancer detection using local binary pattern features and explainable artificial intelligence (AI) techniques.基于迁移学习的方法,利用局部二值模式特征和可解释人工智能(AI)技术进行肺癌和结肠癌检测。
PeerJ Comput Sci. 2024 Apr 19;10:e1996. doi: 10.7717/peerj-cs.1996. eCollection 2024.
6
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis.微卫星高度不稳定早期胃癌的辅助化疗和新辅助化疗:一项系统评价与荟萃分析
Ther Adv Med Oncol. 2024 Feb 29;16:17588359241231259. doi: 10.1177/17588359241231259. eCollection 2024.
7
Emerging Targets for Systemic Treatment of Gastric Cancer: HER2 and Beyond.胃癌全身治疗的新兴靶点:HER2及其他
J Gastric Cancer. 2024 Jan;24(1):29-56. doi: 10.5230/jgc.2024.24.e6.
8
Global burden, risk factors, clinicopathological characteristics, molecular biomarkers and outcomes of microsatellite instability-high gastric cancer.全球负担、风险因素、临床病理特征、分子生物标志物和微卫星不稳定型高胃癌的结局。
Aging (Albany NY). 2024 Jan 12;16(1):948-963. doi: 10.18632/aging.205431.
9
Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy.微卫星不稳定性和HER2阳性在接受围手术期化疗的局部晚期食管胃癌患者中的作用。
Clin Transl Oncol. 2023 Nov;25(11):3287-3295. doi: 10.1007/s12094-023-03179-5. Epub 2023 Apr 21.
10
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.AGAMENON-SEOM模型用于预测接受一线曲妥珠单抗治疗的晚期HER2阳性食管胃腺癌患者的生存率。
Ther Adv Med Oncol. 2023 Mar 4;15:17588359231157641. doi: 10.1177/17588359231157641. eCollection 2023.
Front Oncol. 2020 Jul 28;10:1269. doi: 10.3389/fonc.2020.01269. eCollection 2020.
4
A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability.具有潜在临床适用性的智利胃癌患者的分子分层
Cancers (Basel). 2020 Jul 10;12(7):1863. doi: 10.3390/cancers12071863.
5
The expression of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2 based on tumor location affect survival in gastric cancer.基于肿瘤位置的表皮生长因子受体1和人表皮生长因子受体2的表达影响胃癌患者的生存。
Medicine (Baltimore). 2020 May 22;99(21):e20460. doi: 10.1097/MD.0000000000020460.
6
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.曲妥珠单抗-德曲妥珠单抗用于既往治疗的 HER2 阳性胃癌。
N Engl J Med. 2020 Jun 18;382(25):2419-2430. doi: 10.1056/NEJMoa2004413. Epub 2020 May 29.
7
Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.在中国人群中,TCGA 和 ACRG 分类在胃癌中的临床特征和预后意义。
Mol Med Rep. 2020 Aug;22(2):828-840. doi: 10.3892/mmr.2020.11183. Epub 2020 May 22.
8
Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?免疫组织化学标志物在表型胃癌分类中是否有用?
Oncology. 2020;98(8):566-574. doi: 10.1159/000506077. Epub 2020 Apr 21.
9
Integrated immune gene expression signature and molecular classification in gastric cancer: New insights.胃癌中整合的免疫基因表达特征和分子分类:新见解。
J Leukoc Biol. 2020 Aug;108(2):633-646. doi: 10.1002/JLB.4MR0120-221R. Epub 2020 Mar 14.
10
Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications.基于肿瘤微环境的胃癌免疫分子亚群的鉴定和验证:免疫治疗意义。
Cancer Immunol Immunother. 2020 Jun;69(6):1057-1069. doi: 10.1007/s00262-020-02525-8. Epub 2020 Feb 25.